Through the discovery of a link between endosomal recycling, enhanced degradation, and a resultant altered trafficking of proteins within the proximal tubules, the present study provides the basis for evaluating rififylin as a novel candidate gene for renal disease characterized by proteinuria in humans. Here, RFFL is linked to kidney disorder.